Retroceder
7. Lactancia materna y fármacos antiasmáticos
7.12 TEOFILINA

Teofilina. Lactancia. Riesgo Un caso descrito de nauseas, vómitos e irritabilidad, pero la teofilina se emplea para tratar las apneas en prematuros. Puede incrementar la producción de leche por aumento de prolactina.

Nivel 0: Riesgo muy bajo. Compatible y sin riesgo para la lactancia y el lactante.

  • Athavale MA, Maitra A, Patel S, Bhate VR, Toddywalla VS.Development of an in vitro cell culture model to study milk to plasma ratios of therapeutic drugs.Indian J Pharmacol.2013;45:325–9.
  • Muresan M.Successful relactation--a case history.Breastfeed Med.2011;6:233–9.
  • National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program Asthma and Pregnancy Working Group.NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. J Allergy Clin Immunol. 2005;115:34–46.
  • National Asthma Education and Prevention Program.Quick Reference from the Working Group Report on Managing asthma during pregnancy: recommendations for pharmacologic treatment. Update 2004. 2005.
  • World Health Organization; UNICEF. Breastfeeding and Maternal MedicationRecommendations for Drugs in the Eleventh WHO Model List of Essential Drugs.Department of Child and Adolescent Health and Development. 2002.
  • American Academy of Pediatrics Committee on Drugs.Transfer of drugs and other chemicals into human milk.Pediatrics.2001;108:776–89.
  • Nice FJ, Snyder JL, Kotansky BC.Breastfeeding and over-the-counter medications.J Hum Lact.2000;16:319–31.
  • Bucher HU, Gautschi K.[Detection of caffeine, theophylline and theobromine in the umbilical cord blood and breast milk].Helv Paediatr Acta.1985;40:163–7.